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Shiga-toxin-producing Escherichia coli (STEC) O157:H7 is a recently emerged zoonotic pathogen with considerable mor-
bidity. Since the emergence of this serotype in the 1980s, research has focussed on unravelling the evolutionary events from
the E. coli O55:H7 ancestor to the contemporaneous globally dispersed strains observed today. In this study, the genomes
of over 1000 isolates from both human clinical cases and cattle, spanning the history of STEC O157:H7 in the UK, were
sequenced. Phylogenetic analysis revealed the ancestry, key acquisition events and global context of the strains. Dated phy-
logenies estimated the time to evolution of the most recent common ancestor of the current circulating global clone to be
175 years ago. This event was followed by rapid diversification. We show the acquisition of specific virulence determinates
has occurred relatively recently and coincides with its recent detection in the human population. We used clinical outcome
data from 493 cases of STEC O157:H7 to assess the relative risk of severe disease including haemolytic uraemic syndrome
from each of the defined clades in the population and show the dramatic effect Shiga toxin repertoire has on virulence.
We describe two strain replacement events that have occurred in the cattle population in the UK over the last 30 years, one
resulting in a highly virulent strain that has accounted for the majority of clinical cases in the UK over the last decade. There is
a need to understand the selection pressures maintaining Shiga-toxin-encoding bacteriophages in the ruminant reservoir and
the study affirms the requirement for close surveillance of this pathogen in both ruminant and human populations.
Keywords: emerging infections; Escherichia coli; genomics; One Health; public health microbiology; Shiga toxin.
Abbreviations: HUS, haemolytic uraemic syndrome; ML, maximum-likelihood; NESSS, National Enhanced Surveillance
System for STEC; SBI, Stx-associated bacteriophage insertion; SNP, single nucleotide polymorphism; STEC, Shiga-toxin-
producing Escherichia coli?
Data statement: Two supplementary figures and five supplementary tables are available with the online Supplementary
Material. All supporting data, code and protocols have been provided within the article or through supplementary data files.
Received 17 May 2015; Accepted 22 July 2015
G 2015 The Authors. Published by Society for General Microbiology 1
Downloaded from www.microbiologyresearch.org by
IP:  143.234.194.72
On: Mon, 12 Nov 2018 13:59:37
Data summary
1. FASTQ sequences were deposited in the NCBI Short
Read Archive under the BioProject PRJNA248042
(http://www.ncbi.nlm.nih.gov/bioproject/?term5PRJNA
248042)
2. Supplementary Table 5 is available at the follow-
ing git repository: https://github.com/timdallman/
phylogenomics_stec.git
Introduction
Shiga-toxin-producing Escherichia coli (STEC) O157:H7 is
a globally dispersed pathogen that, whilst generally asymp-
tomatic in its ruminant host, can cause severe outbreaks of
gastroenteritis, haemorrhagic colitis and haemolytic urae-
mic syndrome (HUS) in humans [Akashi et al., 1994; Cen-
ters for Disease Control and Prevention (CDC), 2006;
Ihekweazu et al., 2012]. Contemporary STEC O157:H7
represent a monomorphic clone (Whittam et al., 1988)
characterized by particular phenotypic properties includ-
ing the inability to ferment sorbitol and produce b-glucur-
onidase. Over the course of its evolution, STEC O157:H7
has acquired several virulence determinants including
two types of Shiga toxins (Stx1 and Stx2) encoded on
lambdoid bacteriophages (Scotland et al., 1985), a
myriad of effector proteins (Lai et al., 2013; Tobe et al.,
2006) and a virulence plasmid containing genes for a
type II secretion system and a haemolysin (Schmidt
et al., 1994). It is postulated that the current clone arose
with the transfer of the O157 rfb and gnd genes that specify
the structure of lipopolysaccharide side-chains that com-
prise the somatic (O) antigens into a stx2 containing
E. coli O55:H7 strain that had an enhanced capacity for
host colonization mediated by the locus of enterocyte
effacement (LEE) pathogenicity island (Wick et al.,
2005). A step-wise sequence of events involving the loss
of the ability to utilize sorbitol, lysogenization by an
stx1-containing phage and inactivation of the gene encod-
ing the b-glucuronidase uidA is hypothesized to have given
rise to the currently circulating clone (Feng et al., 1998),
with distinct subpopulations formed by less common
non-motile O157:H strains and strains that retained the
ability to express b-glucuronidase.
Despite high levels of relatedness of the non-sorbitol-
fermenting, b-glucuronidase-negative STEC O157:H7
strains, it has long been realized that distinct lineages
exist within the population. It is suggested that these
arose from the result of geographical spread of an ancestral
clone and subsequent regional expansion (Kim et al., 2001;
Yang et al., 2004). Identified subpopulations have also been
found to be unequally distributed in the cattle and human
populations with lineage I being more prevalent among
human clinical isolates and lineage II more associated with
the animal host (Yang et al., 2004). Subsequent studies
revealed differences between the two lineages including
Stx-encoding bacteriophage (Stxw) insertion sites (Besser
et al., 2007), stx2 expression (Dowd & Williams, 2008) and
stress resistance (Lee et al., 2012), as well as lineage-specific
polymorphisms (Bono et al., 2007). Further characterization
of genomic differences between these two lineages identified
an intermediate genogroup termed lineage I/II (Zhang et al.,
2007). To investigate the propensity of different STEC
O157:H7 strains to cause serious illness, further subtyping
schemes have been developed which subdivided the popu-
lation into nine clades based on single nucleotide poly-
morphisms (SNPs; Manning et al., 2008; Riordan et al.,
2008) with clade 8 associated with two large outbreaks of
HUS (Manning et al., 2008). Subsequent in vitro studies
showed varied adherence and virulence factor expression
between different clades (Abu-Ali et al., 2010) and whole
genome studies elucidated further potential virulence deter-
minants (Eppinger et al., 2011a). The use of clade geno-
typing provided further evidence that the diversity within
STEC O157:H7 is globally distributed (Mellor et al., 2013;
Yokoyama et al., 2012).
Several groups have used the clade description of the STEC
O157:H7 population to further speculate on the evolution-
ary path that has given rise to the current diversity (Kyle
et al., 2012; Leopold et al., 2009; Yokoyama et al., 2012).
The current model suggests that b-glucuronidase-positive,
non-sorbitol-fermenting STEC O157:H7 (clade 9) are
ancestral to lineage II and the intermediate lineage I/II
(which overlap with clades 8–5) which themselves are
ancestral to lineage I (clades 5–1). The nature of the para-
phyletic evolution of these lineages, however, remains
unknown.
Impact statement
In this article, we analyse over 1000 Shiga-toxin-pro-
ducing Escherichia coli (STEC) O157:H7 genomes
from animal and clinical isolates collected over the
past three decades and present for the first time a com-
prehensive population structure of STEC O157:H7.
Using phylogenetic methods we have examined the
origin and dispersal of this zoonotic pathogen and
show how historical worldwide dissemination fol-
lowed by regional expansion in native cattle popu-
lations gave rise to the extant diversity seen today.
By comparing clinical outcome data of nearly 500
human cases we comprehensively assess the associ-
ation between phylogenetic grouping, acquisition
and loss of specific subtypes of Shiga toxin, and
severe disease. With this analysis, we show specific cir-
culating strains carry w fivefold increased risk of
severe disease than the ancestral STEC O157:H7 geno-
type. Finally, we show that recent strain replacement
has occurred in Great Britain shaping the diversity
of STEC O157:H7 observed today and introducing a
high virulence clone into the British cattle population.
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The UK has a comparatively high human infection rate
with STEC O157 (Chase-Topping et al., 2008) and this
has remained relatively constant over the last decade.
In the UK, STEC O157 strains are subtyped by determining
sensitivity to a specific panel of 16 typing phages, a phage
typing scheme developed in Canada and adopted by several
European countries (Ahmed et al., 1987; Khakhria et al.,
1990). Over the last decade in England, Scotland and
Wales, phage type (PT) 21/28 strains have been most com-
monly associated with severe human infection, and more
recent research has indicated that these strains are more
likely to be associated with high excretion levels from
cattle, known as supershedding (Chase-Topping et al.,
2008). Previously, the most common phage type in Eng-
land, Scotland and Wales was PT2 until it decreased year
after year from 1998 (see Fig. 1). The nature of this
strain replacement and how PT21/28, PT2 and other
common phage types, such as PT8 and PT32, are associ-
ated with each other and with the lineages defined above
was not understood. In this study we present the popu-
lation structure of STEC O157:H7 from a UK perspective
using genome sequencing of over 1000 animal and clinical
isolates collected over the past three decades. Using phylo-
genetic methods we have examined the origin and dispersal
of this zoonotic pathogen and estimated approximate evol-
utionary timescales that have led to the emergence of an
expanded virulent cluster that accounts for a significant
proportion of the human STEC disease in the UK.
Methods
Strain selection. A total of 1075 strains of STEC O157
from clinical and animal isolates from England, Northern
Ireland, Wales and Scotland collected from 1985 to
2014 were selected for sequencing. These represented 25
phage types. Ninety-five cattle strains were STEC O157:
H7 isolates selected for sequencing from Scottish cattle
strains collected as part of ‘The Wellcome Foundation
International Partnership Research Award in Veterinary
Epidemiology’ (IPRAVE) study on the basis of regional
and genotypic diversity. Fifty-four sequences were
downloaded from public repositories including the oldest
sequenced STEC O157 (Sanjar et al., 2014).
Genome sequencing and sequence analysis. Genomic
DNA was fragmented and tagged for multiplexing with
Nextera XT DNA Sample Preparation kits (Illumina) and
sequenced at the Animal Laboratories and Plant Health
Agency using the Illumina GAII platform with 2|150 bp
reads. Short reads were quality-trimmed (Bolger et al.,
2014) and mapped to the reference STEC O157 strain
Sakai (GenBank accession BA000007) using BWA-SW
(Li & Durbin, 2010). The sequence alignment map output
from BWA was sorted and indexed to produce a binary
alignment map (BAM) using Samtools (Li et al., 2009).
GATK2 (McKenna et al., 2010) was used to create a
variant call format (VCF) file from each of the BAMs,
which were further parsed to extract only SNP positions
which were of high quality (MQi30, DPi10, GQi30,
variant ratio i0.9). Pseudosequences of polymorphic
positions were used to reconstruct maximum-likelihood
trees using RaxML (Stamatakis, 2014). Pairwise SNP
distances between each pseudosequence were calculated.
Spades version 2.5.1 (Bankevich et al., 2012) was run using
careful mode with kmer sizes 21, 33, 55 and 77 to produce
de novo assemblies of the sequenced paired-end fastq files.
SNP clustering. Hierarchical single linkage clustering
was performed on the pairwise SNP difference between
all strains at various distance thresholds (D250, D100,
D50, D25, D10, D5, D0). The result of the clustering is a
SNP address that can be used to describe the population
structure based on clonal groups.
Recombination. Recombination analysis was performed
using BRATNEXTGEN (Marttinen et al., 2012). Represen-
tatives from D50 SNP clusters were randomly selected and
whole-genome alignments produced relative to the reference
strain Sakai. From the proportion of shared ancestry
generated by BRATNEXTGEN, the dataset was partitioned into
18 clusters. Recombination between and within these
clusters was calculated over 20 iterations and the significance
estimated over 100 replicates. Recombinant segments
detected were deemed significant with a P valuev0.05.
Timedphylogenies. Timed phylogenies were reconstructed
using BEAST-MCMC v1.80 (Drummond et al., 2012) and after
first confirming a temporal signal using Path-O-Gen
(Drummond et al., 2012). Alternative clock models and
population priors were computed and their suitability
assessed based on Bayes factor (BF) tests. The highest
supported model was a relaxed lognormal clock rate under
a constant population size. All models were run with a
chain length of one billion. A maximum clade credibility
tree was reconstructed using TreeAnnotator v1.75.
Fig. 1. Proportion of cases of the predominant phage types in
England and Wales, and Scotland over the last 20 years.
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Shiga toxin subtyping. Shiga toxin subtyping was
performed as described by Ashton et al. (2015).
Stx-associated bacteriophage insertion (SBI). The
integration of Shiga-toxin-carrying prophage into the
host genome has been characterized into six target genes:
wrbA (Hayashi et al., 2001), which encodes a NADH
quinone oxidoreductase; yehV (Yokoyama et al., 2000), a
transcriptional regulator; sbcB (Ohnishi et al., 2002), an
exonuclease; yecE, a gene of unknown function; the
tRNA gene argW (Eppinger et al., 2011a); and Z2577,
which encodes an oxidoreductase. Intact reference
sequences of these genes were obtained and compared by
BLASTN BLAST(Altschul et al., 1990) against the STEC
O157:H7 genome assemblies. Occupied SBI sites were
defined as those strains that had disrupted BLAST
alignments.
Clade typing. Clade typing was performed as originally
defined by Manning et al. (2008). The eight definitive
polymorphic positions adopted by Yokoyama et al.
(2012) were used to delineate the strains into the nine
clade groupings.
Locus-specific polymorphism assay – LSPA6. Based
on the polymorphic genes defined by Yang et al. (2004),
reference sequences of six genes were extracted from the
Sakai reference genome. Sequence alignments were
generated using BLASTN of these sequences against the
STEC O157:H7 genome assemblies. The allelic designation
‘1’ was assigned to WT, ‘2’ assigned to the insertions/
deletions defined by Yang et al. (2004) and ‘X’ to all other
polymorphisms.
Each allele ( folD-sfmA, Z5935, yhcG, rbsB, rtcB and arp-
iclR) was assigned a number as described previously
(Yang et al., 2004). Isolates showing the LSPA6 genotype
1-1-1-1-1-1 were classified as LSPA6 lineage I (LSPA6
LI), while those with LSPA6 genotype 2-1-1-1-1-1 were
classified as LSPA6 lineage I/II (LSPA6 LI/II). Unique
alleles (aberrant amplicon size) were assigned new num-
bers. All deviations from the genotypes 1-1-1-1-1-1 and
2-1-1-1-1-1 were classified as LSPA6 lineage II (LSPA6 LII).
Statistical analyses of clinical data amongst clinical
cases reported in England. The National Enhanced
Surveillance System for STEC (NESSS) in England was
implemented on 1 January 2009, and has been described
in detail elsewhere (Byrne et al. 2015). In brief, it collates
standardized demographic, clinical and exposure data on
all cases of STEC reported in England through collection
of a standard enhanced surveillance questionnaire (ESQ).
For this study, clinical data on clinical cases for whom
strains were sequenced were extracted from NESSS.
These data included whether the case reported symptoms
of non-bloody diarrhoea, bloody diarrhoea, vomiting,
nausea, abdominal pain, fever or whether they were an
asymptomatic carrier detected through screening high-
risk contacts of symptomatic cases. Data on whether cases
were hospitalized, developed typical HUS or died were
also extracted. The age and gender of cases were also
extracted. Where clinical symptoms were blank on the
ESQ and cases were not recorded as being asymptomatic,
these were coded as negative responses. Cases were
categorized into children (aged 16 and under) or adults,
based on a priori knowledge that children are most at risk
of both STEC infection and progression to HUS (Byrne
et al., 2015). While adults aged over 60 are at increased
risk of STEC infection and development of HUS, they
were under-represented in these data and were not
analysed as a separate group. The outcome of interest was
disease severity. Cases were coded as having severe disease
if any of the following criteria were reported: bloody
diarrhoea, hospitalization, HUS or death. Asymptomatic
cases and cases with non-bloody diarrhoea were classed
as mild.
Genomic variables for analyses included Stx subtype and
sublineage. Sublineages were described with respect to Stx
subtypes. Cases were described with respect to clinically
mild or severe disease and HUS separately by sublineage.
Disease severity was compared amongst gender and age
of cases, and sublineage, and Fisher’s exact tests were
used to compare proportions. Logistic regression analysis
was used to investigate phylogenetic groups associated
with more severe disease outcomes. Due to the correlation
between Stx subtypes and lineage, sublineage was chosen as
an explanatory variable for analyses. To assess whether
there was a difference in disease severity within sublineages,
they were further subdivided by Stx subtype for analysis.
Odds ratios for cases reporting severe disease compared
with those reporting mild disease were calculated for
each variable. Lineage IIa was chosen as the baseline for
lineages as it was found to be the ancestral O157 lineage.
Results
Phylogeny of STEC O157 in the UK
A maximum-likelihood (ML) phylogeny (Fig. S1 available
in the online Supplementary Material) revealed the popu-
lation structure of the STEC O157 isolates sequenced in
this study. The STEC O157:H7 population has previously
been delineated into three lineages, I, I/II and II (Feng
et al., 1998; Zhang et al., 2007), and the phylogeny pre-
sented here also splits the strains into three groups via
deep branches, with reference strains of known lineage
(Eppinger et al., 2011b) conforming to the expected
pattern.
The ML phylogeny was compared with two other previously
used methods to describe the STEC O157 population,
namely LSPA6 type (Yang et al., 2004) (Fig. S1a) and the
Manning clade typing scheme (Manning et al., 2008) (Fig.
S1b). LSPA6 typing was not congruent with the phylogeny
and the lineages defined by LSPA type do not reflect
the phylogenetic clustering generated on polymorphisms
T. J. Dallman and others
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across the whole genome. By LSPA6, the only strains that
typed as lineage I (LSPA6 1-1-1-1-1-1) were a clade contain-
ing the lineage I strain the assay was designed upon,
EDL933. Other strains that cluster within this deep branch
(and therefore should be of the same lineage) typed as line-
age I/II (LSPA6 2-1-1-1-1-1) or had a novel polymorphism.
Similarly across the rest of the ML phylogeny, the predomi-
nant LSPA6 was 2-1-1-1-1-1 or a novel polymorphism.
Based on this population, LSPA6 typing did not resolve
the lineages correctly and, therefore, we defined the lineages
I, I/II and II on the basis of the deep phylogenetic branches
and the placement of reference strains of known lineage.
Fig. S1b shows the phylogeny coloured by clades as
described by Manning et al. (2008). The clade groupings
were broadly congruent, with the phylogeny clade 7
(purple), clade 8 (pink) and clade 4/5 (blue) predominat-
ing and clade 9 (bright green), comprising strains that were
b-glucuronidase-positive, as an outgroup. It was clear,
however, that clade typing does not resolve many phyloge-
netic splits. In terms of clade typing, lineage II corre-
sponded to clade 7, lineage I/II corresponded to clade 8
and lineage I corresponded to clades 6 through 1 as
suggested previously (Eppinger et al., 2011a).
Single linkage clustering based on pairwise genetic distance
is an effective method of defining phylogenetic groups as
it is inclusive of clonal expansion events. Using a SNP dis-
tance threshold of D250 we clustered the 1224 strains in
this study into 54 groups. Of these, 52/54 clusters were dis-
tributed within the three lineages and there were two outlier
clusters, one contained the b-glucuronidase-positive strains
and another contained three isolates associated with travel
to Turkey. Fig. S2 shows the number and size of the 52 clus-
ters within the three lineages. Lineage II contained the most
diversity with 32 clusters whilst lineage I and lineage I/II
contained 17 and 3 clusters, respectively. All three lineages
were associated with uneven sampling of diversity with
single high-density clusters comprising 77 % of lineage I iso-
lates, 73 % of lineage I/II isolates and 47 % of lineage II iso-
lates. Isolates contained within the high-density clusters in
lineage I, I/II and II represented the common phage types
associated with human infection in the UK: PT21/28, PT2
and PT8, respectively. Isolates in clusters with five or less
representatives were more likely to be non-UK strains
associated with foreign travel or imported food. Ninety-
five isolates were from cattle faecal pats collected as part
of a large survey in Scotland (Pearce et al., 2009). These
cattle isolates were present in only 8/54 clusters across the
three lineages with 84 % found in the three high-density
clusters identified above. This pattern of uneven diversity,
coupled with the association of domestic cattle with high-
density clones, supports the model of global dispersion
and regional expansion of STEC O157:H7.
Recombination
Signals of recombination in the sample population were
analysed with BRATNEXTGEN using 270 D50 SNP threshold
cluster representatives. There were 631 016 recombinant
positions found across the 5 498 450 bp alignment and
90 % had their origin in the 18 Sakai prophages (SP) or 6
Sakai prophage like elements (SPLE) suggesting that
almost all genetic transfer (at least historical) was phage-
mediated. The median recombinant size was 575 bp whilst
the largest was 41 212 nt representing an intra-lineage II
recombination of SP1. Recombination events were seen at
least twice as frequently within lineages (Table S1) than
between lineages, with no statistical difference association
between the lineage and its likelihood to be a donor or reci-
pient.Within lineage II, the ancestral lineage (see Fig. 2) line-
age IIa appeared to be the donor of most recombination
events with lineage IIc only receiving foreign DNA. Lineage
I had the highest intra-lineage recombination rate, and this
could have contributed to the heterogeneous stx comp-
lement as described in more detail below.
Evolutionary timescale and Stx prophage
insertion in STEC O157
A timed phylogeny was reconstructed using BEAST (Fig. 2).
The mutation rate of STEC O157:H7 was calculated to be
approximately 2.6 mutations genome21 year21 [95 %
highest posterior density (HPD), 2.4–2.8], which is in-
line with previous estimates for E. coli (von Mentzer
et al., 2014) and closely related Shigella species (Holt
et al., 2012). We predict the split of the contemporary
b-glucuronidase-negative, sorbitol-negative clone from
the b-glucuronidase-positive ancestor to be approximately
400 years ago (95 % HPD, 520 years–301 years). The time
to common ancestor of the current circulating diversity
(e.g. lineage I, I/II and II) is approximately 175 years
(95 % HPD, 198 years–160 years), significantly more
recent than previous estimates of 400 years (Yang et al.,
2004) and 2500 years (Leopold et al., 2009). Lineage II is
the ancestral lineage, which contains at least three subli-
neages that diverged early in the evolutionary process.
The most recent common ancestor to lineage I and lineage
I/II existed approximately 150 years ago (95 % HPD, 175
years–130 years).
The model of Shiga toxin acquisition proposed by Wick
et al. (2005) and Feng et al. (1998) suggested the acqui-
sition of a lambdoid phage containing stx2 followed by
the later acquisition of an stx1-containing-phage (Stx1w).
The timed phylogeny supported this hypothesis (Fig. 2)
as the b-glucuronidase-positive ancestor and the majority
(70 %) of strains within lineage IIa and IIb contained
only stx2c. Sublineage lineage IIc (PT8) (Fig. 2) was
subsequently lysogenized by an Stx1w and had the same
disrupted Shiga toxin insertion targets, yehV and sbcA,
supporting the hypothesis that a truncated prophage was
replaced with a Stx1w in yehV (Shaikh & Tarr, 2003).
The majority of strains in Lineage IIb (PT4/PT1) (Fig. 2)
carried stx2c only but had an occupied argW SBI site.
There was some further observed heterogeneity in the
ancestral lineage IIa with small numbers of dispersed
Phylogenomics of STEC O157:H7 in the UK
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Fig. 2. Maximum clade credibility tree of 530 D25 SNP representatives. The tree is highlighted by lineage and the loss and gain of Stxw
with the associated SBI in parentheses. The GUD+ lineage represents the strains that retained the ability to express b-glucuronidase.
Scale is in years.
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strains containing Stx1w, Stx2wa or being negative for any
Shiga toxin alleles as well as having non-Stx disrupted SBI
sites (Table S2).
The common ancestor of lineage I/II (Fig. 2) was approxi-
mately 95 years old, marking the divergence of the strain
that caused the 2006 Taco Bell outbreak in North America
(Sodha et al., 2011) and the PT2 strains associated with the
first outbreak of HUS in the UK in 1983 (Taylor et al.,
1986). The majority (65 %) of strains in lineage I/II were
positive for both stx2c and stx2a with occupied SBIs at
yehV, sbcA and argW. One sub-group of strains belonging
to PT2 have subsequently lost Stx2cw and had an intact
sbcA (Table S3).
Lineage I was by far the most heterogeneous in terms of
Stx complement (Table S4) and arose from a stx2c-only
ancestor approximately 125 years ago (Fig. 2). The
majority (87 %) of strains in Lineage Ib (PT32) retained
the ancestral stx2c only genotype of lineage II and had
an additional yecE SBI occupied. This lineage had an
overrepresentation of strains from Scottish cattle and
very few clinical strains. The majority (64 %) of strains
in lineage Ia contained Stx2aw and Stx1w with dis-
rupted yehV and wrbA including the first fully
sequenced STEC O157:H7 genomes [Sakai (Hayashi
et al., 2001) and EDL-933 (Latif et al., 2014)] and the
genome sequence of E. coli O157:H7 strain 2886-75,
which was isolated in 1975 making it the oldest STEC
O157:H7 strain for which a genome sequence is avail-
able (Sanjar et al., 2014). Lineage Ia also contained
strains that typed as clade 6 by the Manning scheme
and carry the stx2c and stx2a genes with disrupted
yehV and sbcA, which suggests either Stx2aw inserted
into yehV or a novel insertion site.
A final sublineage of lineage I (lineage Ic) contained 40 %
of the strains in this study and its common ancestor was
approximately 50 years old and had since diverged into
three clades. These included the ancestral stx2c-only geno-
type with occupied yehV and sbcA SBIs, a stx2a-only gen-
otype with occupied yecE and yehV insertion sites, and a
stx2a and stx2c genotype with occupied SBIs yehV, sbcA
and argW. This final genotype was predominated by
phage type 21/28. Within the PT 21/28 clade, a subclade
had subsequently lost the stx2c toxin although yehV, sbcA
and argW remain occupied.
All 1129 genomes analysed in this study are summarized in
terms of lineage, SNP cluster, SBI, stx type, Manning Clade
and LSPA-6 type in Table S5.
Recent emergence of predominant UK lineages
The phage types PT8 and PT21/28 accounted for approxi-
mately 60 % of clinical isolates identified in the UK in
Fig. 3. Left, maximum-likelihood phylogeny of 400 lineage I D5 SNP representatives with lineage Ic highlighted in grey. Right, maximum-
likelihood phylogeny of lineage Ic showing the radial expansion of PT21/28 from the PT32 ancestor with isolates annotated by cattle or
clinical origin. Scale represents substitutions per site.
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2014. Phage typing of STEC O157:H7 in the UK suggests
strain replacement has occurred since the beginning of
the 21st century with a decline in PT2 corresponding
with a rise in PT21/28. PT2 was restricted to lineage I/II
whereas PT21/28 was restricted to lineage I indicating
strain replacement of one genotype by another distinct
genotype, rather than phage type switching within a
single genotype.
PT 21/28 typically accounts for w30 % of clinical isolates
seen in the England, Wales and Scotland each year and is
the phage type most commonly associated with outbreaks
of HUS (Underwood et al., 2013). As stated above, diver-
gence from the most recent common ancestor occurred
50 years ago subsequently created 3 clades: the ancestral
PT32 stx2c-only genotype, a stx2a-only PT32 genotype
associated with travel to Ireland and mainland Europe
and finally the PT21/28 clade as a single D50 SNP cluster.
The PT21/28 clade contained a large number of British
cattle (57 % of total cattle isolates) and clinical isolates
but very few isolates associated with foreign travel
(v1 %). The PT21/28 clade arose only 25 years ago and
has since undergone a radial expansion resulting in a
‘comet’ like phylogeny (Fig. 3). The PT 21/28 clade itself
was flanked by three PT32 stx2a and stx2c isolates, two
from cattle and one clinical isolate from Scotland. It is
clear that the direct ancestor of PT21/28 is a PT32 strain.
PT8 was represented as a single D250 SNP clonal group
(lineage IIc) and its most recent common ancestor can be
dated to approximately 50 years ago. Across this clonal
group, cases were associated with travel to southern
Europe and northern Africa (22 %) suggesting this strain
may be endemic in cattle in this region. Within this group
there was a recently emerged (30 years to most recent
common ancestor) subclade where several cases reported
exposure to domestic cattle, cases reported no foreign
travel, and there were several strains from UK cattle, sugges-
tive of a domestic source of human infection (Fig. 4). This
again highlights the possibility of imported strains of
O157:H7 becoming endemic in local cattle populations.
Disease severity of clinical cases in England by
stx subtype and sublineage
A total of 493 strains from clinical cases in England had
clinical data available in NESSS. Of those, 311 (63.1 %)
had experienced bloody diarrhoea, 158 (32.0 %) had been
Fig. 4. Left, maximum-likelihood phylogeny of 241 lineage II D5 SNP representatives with lineage IIc (PT8) highlighted in grey. Right,
maximum-likelihood phylogeny of lineage IIc showing the distribution of Mediterranean-travel-associated cases and UK cattle cases. Scale
represent substitutions per site.
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hospitalized with their illness and 26 (5.3 %) were from
cases known to have developed HUS. Thus, two thirds of
cases in the dataset were categorized as having severe disease
(as defined in methods); however, this varied by stx subtype
and sublineage (Table 1). Cases classed as having mild dis-
ease accounted for 33.5 % of the dataset, and included 18
asymptomatic cases. Over half (55.4 %) of cases in the data-
set were female and 55.2 % were children aged 16 and
under. Severe disease was more frequently reported amongst
females (70.3 % versus 29.7 %, P50.044) and children
(71.9 % versus 28.1 %, P50.005).
In univariable analysis, being a child and being female were
significantly associated with severe disease (Table 2). All
sublineages, except Ib and Ic carrying stx2c, were signifi-
cantly associated with more severe disease as compared
with sublineage IIa. In the final multivariable model
when all variables were controlled for, being a child was
a significant predictor of severe disease, but being female
was no longer significant. Sublineage Ia had the greatest
odds of severe disease, with a sixfold-increased odds as
compared with IIa.
All but one of the HUS cases fell within sublineages Ic and
I/II (Fig. 1) and all were infected with strains carrying stx2a
either alone or with stx2c (Table 2). Lineages Ic and I/II
were further divided into strains possessing stx2a only
and those with stx2a/2c. Across all strains, there was no
difference in disease severity between cases infected with
strains carrying stx2a alone or with 2c (53.5 % versus
46.5 %, P50.291). However, in both sublineages Ic and
I/II, strains carrying stx2a only had higher odds of severe
disease than those carrying stx2a/2c in the final model.
While sublineage IIc had increased odds of severe disease,
no cases developed HUS. Rather, this was due to increased
reporting of bloody diarrhoea amongst cases infected with
these strains compared with those in other sublineages
(75.6 % versus 58.6 % in other sublineages, P50.005).
Most strains (92 %) in this sublineage carried stx1a/2c.
Overall, cases infected with strains carrying stx1a reported
bloody diarrhoea more frequently than those without
(77.5 % versus 61.8 %, P50.001) leading to the hypothesis
that possession of stx1a in strains of sublineage IIc leads to
higher rates of bloody diarrhoea.
Discussion
Using phylogenetic analysis of variation at the whole genome
level we have been able to reconstruct the phylogenetic
Table 1. Sublineage and stx subtype of whole-genome-
sequenced strains isolated from clinical cases of STEC
O157 in England
Sublineage Mild Severe* Total HUSD
n (%) n (%) n (%) n (%)
II a 42 56.8 32 43.2 74 100 1 1.4
II b 18 81.8 4 18.2 22 100 0 0.0
II c 31 23.7 100 76.3 131 100 1 0.8
I a 3 17.7 14 82.3 17 100 0 0.0
I b 7 77.8 2 22.2 9 100 0 0.0
Ic (stx2a) 9 20.9 34 79.1 43 100 8 18.6
Ic (stx2a/2c) 35 30.2 81 69.8 116 100 10 8.6
Ic (stx2c) 1 25.0 3 75.0 4 100 0 0.0
I/II (stx2a) 7 18.4 31 81.6 38 100 2 5.3
I/II (stx2a/2c) 12 30.8 27 69.2 39 100 4 10.3
All strains 165 33.5 328 66.5 493 100 26 5.3
* Includes cases with bloody diarrhoea or cases who were
hospitalized.
DThe lineage IIa strain isolated from a patient with HUS possessed
stx2a/2c; the lineage IIc strain possessed stx1a/2a/2c.
Table 2. Disease severity amongst clinical cases of STEC
O157 in England, where strains had been whole-genome-
sequenced, by age, gender and sublineage
Variable Category Odds
ratio
P value Lower
95 %
CI
Upper
95 %
CI
Univariable analysis
Age Child 1.73 0.005 1.18 2.51
Adult Baseline
Sex Female 1.49 0.037 1.02 2.17
Male Baseline
Sublineage IIa Baseline
IIb 0.29 0.040 0.09 0.95
IIc 4.23 0.000 2.30 7.80
Ia 6.12 0.008 1.62 23.14
I b 0.37 0.240 0.07 1.93
Ic (stx2a) 4.96 ,0.001 2.08 11.80
Ic (stx2a/2c) 2.92 0.001 1.59 5.34
Ic (stx2c) 3.94 0.245 0.39 39.65
I/II (stx2a) 5.81 ,0.001 2.27 14.88
I/II (stx2a/2c) 2.95 0.010 1.30 6.71
Multivariable analysis
Age Child 1.56 0.042 1.01 2.39
Adult Baseline
Sex Female 1.15 0.489 0.76 1.75
Male Baseline
Sublineage IIa Baseline
IIb 0.29 0.040 0.09 0.95
IIc 3.65 ,0.001 1.95 6.83
Ia 6.09 0.008 1.60 23.20
Ib 0.35 0.209 0.67 1.81
Ic (stx2a) 5.05 ,0.001 2.11 12.10
Ic (stx2a/2c) 3.06 ,0.001 1.66 5.67
Ic (stx2c) 3.48 0.293 0.34 35.62
I/II (stx2a) 4.89 0.001 1.88 12.73
I/II stx (stx2a/2c) 2.87 0.012 1.26 6.58
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history and global diversification of the contemporary STEC
O157:H7 clones. The current models of STEC O157:H7
evolution suggest the sero-conversion of an ancestral stx2
E. coli O55 to O157. Subsequent loss of the ability to ferment
sorbitol and of b-glucuronidase activity gave rise to the
common ancestor of the current circulating clone. The evol-
utionary models of Leopold et al. (2009), Kyle et al. (2012)
and Yokoyama et al. (2012) suggest that the b-glucuroni-
dase-positive last common ancestor may have given rise to
lineage II and lineage I/II in a paraphyletic manner with line-
age I/II spawning lineage I (with the acquisition of Stx1-con-
taining lambdoid phage seen in clades 1–3 described by
Manning et al., 2008). However, strains had previously
been identified that confounded these models and indicated
that a more complex explanation was needed (Arthur et al.,
2013; Mellor et al., 2013).
In this study we propose a new evolutionary model based
on our phylogenetic analysis (Fig. 5). In this model, we
maintain the stepwise series of events from STEC O55
to the b-glucuronidase-positive last common ancestor
(A5) that evolved into contemporary lineage II.
We show at least three extant lineages of lineage II includ-
ing the ancestral branch (IIa) as well as a branch that has
acquired Stx1w (IIc). A lineage II Stx2cw-containing
strain independently gave rise to lineage I (approx.
125 years ago) and lineage I/II (approx. 95 years ago).
In lineage I/II, a single integration event of a Stx2aw
into argW has been maintained with a subgroup losing
Stx2cw. Lineage I has a more complex evolutionary his-
tory with a Stx2aw integrating at least three times (once
into wrbA, once into argW, and once into an unknown
site), Stx1w inserting into lineage Ia strains and at least
two loss events of the Stx2cw. The model presented here
shows Stxw loss and gain events that have been fixed in
the population but we also observed many loss and gain
events that appeared to be occurring sporadically within
each lineage as well as occupation of SBIs with imported
O55:H7stx2c+
A3 O157:H7
GUD+sor+stx2c+ 
A4 O157:H-
GUD+sor+stx2c+
A5 O157:H7
GUD+sor-stx2c+
Lineage II
stx2c+
Lineage IIb
stx2c+
Lineage IIc
stx2c+stx1+
Lineage I
stx2c+
Lineage Ia stx2c+  
stx2a+
Lineage Ib 
stx1a+stx2a+-stx2c- 
Lineage Ic stx2c+
stx2a+
Lineage Ic2 
stx2a+stx2c-
Lineage I/II
stx2c+stx2a+
Fig. 5. STEC O157:H7 evolutionary model based on a timed phylogeny of over 1000 genomes showing the key evolutionary splits and
the associated gain and loss of stx-containing prophages. GUD+ represents strains that have the ability to express b-glucuronidase,
sor+ represents strains that have the ability to ferment sorbital.
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DNA that does not encode Stx. This leads to the con-
clusion that the loss and gain of phage is likely to be
highly dynamic but under high selection for retention
in the bovine host. Recombination analysis highlighted
the phage regions to be hotspots of DNA exchange,
with remarkably little activity outside these regions.
In this analysis we predict the split from the b-glucuroni-
dase-positive last common ancestor (A5) to have occurred
approximately 400 years ago with the common ancestor of
the current diversity appearing 175 years ago. At this point
there was an expansion event with the major lineages
formed within 30 or so years. This early diversification of
STEC O157:H7 fits with the extant diversity of STEC
O157:H7 being globally distributed. Although a large
degree of diversity of STEC O157:H7 is seen in the UK, the
distribution of this diversity is uneven. We show that several
pockets of diversity are seen at much higher frequency then
others and that the same pockets of diversity are more fre-
quently observed in both human clinical cases and in the
local cattle population. This fits with the model of historical
dissemination of diversity and then regional expansion in
native cattle with occasional sampling of the wider diversity
through imported foodstuff and foreign travel.
Although we have shown the contemporary clone existed
over 100 years earlier, STEC O157:H7 only became a
recognized pathogen in the 1980s (Riley et al., 1983)
after causing outbreaks of severe illness. Whilst STEC
O157:H7 causes gastroenteritis in most infections, a sig-
nificant minority develop more severe symptoms including
HUS. Whilst progression to HUS no doubt has many host
predictors, a clear association with the presence of stx2a
subtype has been shown (Persson et al., 2007). In our
study, we show that the acquisition of the stx2a subtype
occurred relatively recently compared with the other stx
subtypes and is likely to explain the recent emergence of
the STEC O157:H7 serotype as a clinically significant
pathogen. We also show that stx2a is likely to have been
acquired by STEC O157:H7 on multiple occasions, high-
lighting the potential for new, highly virulent clones to
emerge. Finally, it appears that once stx2a is integrated in
a population it tends to be maintained, often at the
expense of stx2c. Recent research has indicated that the
Stx2aw is associated not only with more severe human dis-
ease but also with higher excretion levels in cattle
(Matthews et al., 2013).
Using clinical outcome data on a cohort of nearly 500
STEC O157:H7 cases, we are able to assess the risk of
severe disease of each of the extant lineages and subli-
neages. The presence of stx2a is a pre-requisite for the
development of HUS with 100 % of HUS cases infected
with a strain harbouring this toxin subtype. Multivariable
regression analysis with the ancestral IIa clone as the base-
line shows IIc has a nearly fourfold increase in risk of
severe disease accounted for by in increase in incidence
of bloody diarrhoea. This PT8 clone has acquired a
Stx1w carrying the same Stx as found in Shigella dysenteriae
serotype 1. All sublineages of lineage I and I/II that contain
stx2a have an increased risk of severe disease with the
additional presence of stx2c appearing to have a protective
effect. This presumably reflects regulatory interactions
between the prophages. These analyses show the clear
importance of determining the Stx complement of an
STEC O157 strain when predicting the likely risk of
severe disease and, therefore, case management.
This study shows that recent strain replacement has
occurred in Great Britain shaping the diversity of STEC
O157:H7 observed today. Within lineage II, an importa-
tion of a PT8 strain probably from the Mediterranean
cattle population of southern Europe and northern
Africa occurred within the last 30 years. Similarly,
within the last 25 years the emergence and rapid expan-
sion of PT 21/28 in lineage I in Great Britain led to this
highly virulent subtype being found ubiquitously in dom-
estic cattle. These recent strain replacement events pro-
vide insight into the dynamics of STEC O157:H7
transmission on a national and international scale and
suggest that while the overall diversity of this pathogen
is globally distributed, regionally endemic strains can be
transmitted and eventually become the dominant strain
in the local cattle population. Whilst the imported
strain may play a role in out-competing domestic strains,
agricultural practices such as culling and restocking of
animals, as seen during the foot-and-mouth disease and
bovine spongiform encephalitis (BSE) epidemics may
act as drivers facilitating more rapid strain replacement
(Carrique-Mas et al., 2008).
From the current study it appears the relatively high inci-
dence of STEC O157 human infections in the UK results
from the emergence and expansion of a lineage I PT21/28
clade in the last 25 years, producing strains containing
both Stx2a and Stx2c prophages that are capable of
higher excretion levels from cattle (supershedding) and
can cause severe disease in humans. Therefore, screening
and intervention strategies should be targeting these
strain clusters that are the most significant threat to
human health. Further work is needed to understand
the diversity of host phages that carry Stx and the reasons
behind the proliferation of this cluster. While Stx is
essential for the severe pathology associated with
human STEC disease, the role of the different toxins in
governing supershedding is unknown. Moreover, it is
evident that other genes on Stx-encoding prophages
regulate the expression of bacterial colonization factors,
and this will also impact on the success of the cluster
(Xu et al., 2012).
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